Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Walking away from opioid pain: tiny study tests exercise as a helper

NCT ID NCT05772884

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This small pilot study tested whether a 12-week supervised walking program could help middle-aged adults with opioid use disorder reduce pain and improve mobility. Only 6 people took part, and the main goal was to see if such a program was feasible—whether people would join and stick with it. The results are too early to know if exercise actually helps, but it's a first step toward finding drug-free ways to support recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
supervised aerobic exercise program
What this could lead to
If it works, this could point toward a non-drug way to help people in opioid treatment feel better and move more easily.
What could go wrong
This is a very small pilot study with only 6 participants, so results may not apply to everyone. It only looked at whether people would join and stick with the program, not yet at actual pain or mobility improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

6 people

The number who actually took part.

Started

May 2022

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 64 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults must be aged 21-64 years old * Currently enrolled in OMT (opioid maintenance treatment) or present with at least mild opioid use disorder (endorses at least 2 DSM-V criteria for OUD within a 12-month period), * Insufficiently physically active (defined as exercising \< 20 minutes 3 times/week * Able to understand and speak English * Have a body mass index 18.5-40 kg/m\^2 * Willing and able to visit research center up to one time time/week for 12 weeks * Participants will undergo a supervised maximal exercise test and physical exam by medical supervisor to be cleared for participation. Exclusion Criteria: * Participants must not have heart disease, or had a stroke, uncontrolled diabetes, thyroid condition an eating disorder * An uncontrolled major psychiatric condition (e.g., schizophrenia; conditions that are well-controlled, however \[e.g., anxiety controlled through therapy\] will not be exclusionary), or other medical condition(s) that contraindicate exercise; and may not be participating in a structured exercise training or weight loss program. * Participants cannot be pregnant; pregnancy is exclusionary * One individual per household may enroll.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioid-use disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity opiate dependence Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Florida

    Gainesville, Florida, 32611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.